In 62 patients diagnosed as sporadic amyotrophic lateral sclerosis (sALS), we quantitated serum concentrations of neopterin, ~2-microglobulin. kynurenine and tryptophan. A linear increase with age was demonstrated by neopterin more than by ~2-microglobulin, whereas neither parameter corresponded to individual progression or duration of disease at the time of examination. All serum (n = 79) and cerebrospinal fluid (CSF, n = 11 patients) concentrations remained within reference limits, and serum neopterin always exceeded CSF neopterin. Serum neopterin was not elevated in sALS. and we observed no correlation between circulating IgG isotype concentrations and serum neopterin. Total duration of sALS. as measured in months from the first clinical signs or symptoms to death, seemed. however. to inversely correlate with the mean patient serum neopterin before and after correction for age, and in the absence of any neoplastic process. If confirmed in a larger number of sALS patients, this would parallel a reportedly negative association of CSF neopterin and survival in human immunodeficiency virus (HIV,) infection.
Introduction 125 years after being given its name (1) , sporadic amyotrophic lateral sclerosis (sALS) remains a pathophysiologic mystery (2) . Familial (3), paraneoplastic (4) or superoxide-dismutase deficient (5.6,7,S) variants account for less than 10% of all patients. With efforts going as far as total body lymphoid irradiation (9) , no primary autoimmune pathophysiology has been substantiated, and in contrast to earlier reports (10) , anti-ganglioside antibodies do not identify upper-and-lower-motor neuron degeneration (11) . Chani Author to whom correspondence should be addressed.
Pteridines / Vol. 5 / No. 4 ges in skin texture (12) and dermal ultrastructure (13, 14, 15) as well as elevated circulating immune complexes (16.17,1S) and reduced serum immunoglobulin IgGu (19) suggest an involvement outside the nervous system. The segmental, often asymmetrical expansion of paresis (20) and the invariate bulbar affection in any case with dementia (21) would be compatible with a pathogenic cell-to-cell spread. Serum antibodies against exogenous antigens such as human spuma retroviral (22) maedi-visna (23) or HIV type-2 antigens (24, 23) have to date failed to correspond to clinical progression. Cellular immunity has been implicated by spinal macrophage infiltration (25) , increases in CD4+ /CDS+ T lymphocytes (26) . cortical CD8 + lymphocytic accumulation (27) and delineation of affected ventral horns by activated microglia in sALS but not in hereditary spinal muscular atrophy. Neopterin concentration sensitively indicates cellular immune activation in humans (28) , and monocytes/macrophages produce large amounts of neopterin upon stimulation with interferon-gamma (29) . Beta2-microglobulin (~2-microglobulin) represents the light-chain moiety of the major histocompatibility complex (MHC) class I antigens which are present on all nucleated cells. Considerable amounts of ~2-microglobulin are released by proliferating cells on cytokine signals (30) . In order to detect signs of a subtle cellular immune activation in a disease that may coincide with lymphoma and for which at least two retroviral models exist (31, 32, 33, 34) , we extended the quantifications of neopterin, ~2 -microglob ulin, kynurenine and tryptophan reported earlier (35) .
Patients and methods
For diagnostic criteria and exclusion of inflammatory diseases or dysimmune syndromes see (35) . Mean age at first signs or symptoms of the disease was 55.0 years and mean age at examination 57.2 years (± 13.5 SD, SE = 1.5 years) in 79 patients (mean for men 56.3 y ± 13.1 SD, women 60.2 y ± 14.8 SD).
Circulating IgG immune complexes (CIC) were quantitated by standard Raji cell assay (healthy references <2.5 mg/L, patient normal reference limit 14 mg/L) in sera that had been frozen immediately after centrifugation. Neopterin and ~2-microglobulin were determined by radioimmunoassay (Henning Berlin, Pharmacia Uppsala) as described in detail (36) and levels were compared to previously established reference limits (serum 2.5 mg/L for f32-microglobulin and 8.7 nmol/L for neopterin, cerebrospinal fluid 6.0 nmol/L for neopterin (37) and 2.0 mg/L for ~2-mic roglobulin). Internal 95th percentiles were for tryptophan 50 mol/L serum and 1 to 3 mol/L CSF, and for kynurenine 3.5 mol/L serum and 0.2 mol/L CSF (38) . Human spuma retroviral (HSRV) antibodies were determined in 48 ALS patients, 239 other neurological patients and a total of 729 coded sera as described in (39) using identical recombinant HSRV. envPX envelope and HSRV.gagCA capsid antigens (40) . Positive samples were identified by optical densities more than two standard deviations higher than the mean of controls. For immunglobulin isotype quantification see (19) .
For statistical evaluation, Fisher's exact test was used instead of Chi-Square contingency tables to account for small numbers. and Spearman non-paraSerum ncopterin inCl'cascs with age .;:
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::: metric correlations (r5) with two-tailed Ih to avoid incorrect assumption of Gaussian distribution. All correlations were checked by a Runs Test for deviation from linearity; CI = 95% confidence intervals.
The time from the first clinical signs or symptoms of sALS until death had correlated negatively with age (13, 41) ; for linear correction we used 0.9 months per year from the age of 58 years (42). .
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Results
Serum neopterin ranged from 3 to 10 nmol/L, and f32-microglobulin from 0.6 to 2.6 mg!L serum. As in other populations, age at examination correlated with serum neopterin with a linear increase of 0.08 nmol!L year-1 and without significant sex differences (mean neopterin 5.8 nmol/L ± 1.8 SD, SE = 0.2 at age 58). for f32-microglobulin plotted against these two time axes. Serum neopterin correlated well (rs=0.8, p< 0.001) with f32-microglobulin (Fig. 2) . This correlation proved resistant to correction for age (rs = 0.74, p< 0.001). and led to a mean ratio of serum neopterin (nmoI!L) to serum f32-microglobulin (mg/L) of 3.97 ± 0.18 SE. Patient subgroups according to symptomatology, such as sALS with initially bulbar deficits (n = 5), did not exhibit different patterns of neopterin and f32-microglobulin. In twelve women and 18 men, we simultaneously examined neopterin, f32-microglobulin and anti-human spuma retrovirus (HSRV) serum antibodies by enzyme-linked immunosorbent assay (ELISA). Their neopterin serum concentrations did not distribute differently (Fig. 3) . Corrected for age, serum neopterin and f32-microglobulin did not exceed 110% of upper reference limits even in generalized, tetra paretic and moribund patients. In 11 cases of sALS, cerebrospinal fluid neopterin ranged from < 3.0 (n = 3) to 6.0 nmol!L (n = 9). CSF neopterin from patients participating in a therapeutic trial with intrathecal interferon-1 averaged 36.4 nmol/L. In unmedicated sALS all serum and cerebrospinal fluid (CSF, n= 11 patients) concentrations remained within reference limits, and serum neopterin regularly exceeded CSF neopterin. 0.01 unpaired t-test for nonequal averages). Individual neopterin did not associate with clinical progression, except for one patient with rapidly advancing weakness of respiratory muscles and increase in neopterin from 3.1, 5.9 and 8.2 to 8.3 within 14 months. In all 26 sera of 19 patients who have died to date, serum neopterin correlated inversely with retrospective total duration of disease (r5= --0.49, p<O.05), a correlation that is preserved after correction for age of total duration of disease and serum neopterin (Fig. 4) . If one plots mean neopterin corrected for age against age-adjusted duration of disease for 19 sALS patients, the negative correlation remains. Due to the small number of data points and inapplicability of linear regression calculations, however, the correlation co- Table 1 gives a synopsis of simultaneously quantitated neopterin and immunoglobulin-G3 serum concentrations. We did not observe a significant association in ten sALS patients monitored (Table. 1 ).
Discussion
We demonstrate basically normal /32-microglobulin and neopterin levels in sporadic amyotrophic lateral sclerosis. While activated macrophages have been found infiltrating the spinal cord in ALS (25) , our results render a persisting, generalized cellular immune activation highly unlikely. The cerebrospinal fluid data support this view, and do not support a potentially oligodendrocytotoxic production of tumor necrosis factor alpha (43) . A regional, low-active and weakly immunogenic retroviral gene expression expanding without completion of viral particles (44) , however, may still be compatible with both antiretroviral seroreactivities (45) , normal neopterin, /32-microglobulin and kynurenine levels in serum and CSF, and normal concentrations of sIL-2R in CSF of amyotrophic lateral sclerosis (46) . In contrast to CSF glutamate, CSF tryptophan has been reported to increase during the course of the disease (47) . In a restricted number of patients, we did not confirm elevated CSF tryptophan concentrations.
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If confirmed in a larger number of patients followed until death, a negative correlation between serum neopterin and duration of disease would resemble a markedly inverse correlation between CSF neopterin and survival in HIV-AIDS (48) ; in all sALS patients, however, a detectable neoplastic process had been excluded. As postulated for sensory impairment (49) and rabbit calcium channel antibodies (50) , and dermal desmosin content (15) , another non-motor neuronal change would then associate with a more intensive disease process. Viruses frequently enhance attachment to and entry into host cells by recognizing cellular receptors, e.g. CD. for human immunodeficiency virus (HIV1I2), acetylcholine receptor for rabies, beta-adrenergic receptor for reovirus-3, epidermal growth factor receptor for vaccinia virus and lymphocytic complement receptor CR-2 for EpsteinBarr virus. If functional interferences on a glial or neuronal level (51, 52) are related to (retro-) viral proteins (53, 54, 55) , our data were compatible with non-immunogenic target cell alterations and/or transcriptional changes (56, 57, 58 ). An impaired neuronal, microtubule (59) and collagen (13, 14, 15) metabolism could be a common consequence of nuclear alterations not inherited in the prevalent form of the disease. Individual genomic rearrangements could independently lead to neuronal dysfunction and diverse antibody reactivites. In the case of chronic granulocytic leukemia, a proto-oncogene translocation is associated with both expression of and antibody formation to endogenous human retroviral sequences (60) .
